688065 Stock Overview
A bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Cathay Biotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥34.28 |
| 52 Week High | CN¥57.68 |
| 52 Week Low | CN¥33.75 |
| Beta | 0.47 |
| 11 Month Change | -9.26% |
| 3 Month Change | -27.48% |
| 1 Year Change | -40.08% |
| 33 Year Change | -70.05% |
| 5 Year Change | n/a |
| Change since IPO | -69.43% |
Recent News & Updates
Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up
Sep 07
There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital
Jun 19Recent updates
Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up
Sep 07There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital
Jun 19Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet
May 28What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You
May 07We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings
May 06Shareholder Returns
| 688065 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -5.0% | -2.8% | -2.4% |
| 1Y | -40.1% | -28.2% | -20.1% |
Return vs Industry: 688065 underperformed the CN Chemicals industry which returned -27% over the past year.
Return vs Market: 688065 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
| 688065 volatility | |
|---|---|
| 688065 Average Weekly Movement | 3.8% |
| Chemicals Industry Average Movement | 5.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.7% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 688065's share price has been volatile over the past 3 months.
Volatility Over Time: 688065's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,803 | Xiucai Liu | www.cathaybiotech.com |
Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries.
Cathay Biotech Inc. Fundamentals Summary
| 688065 fundamental statistics | |
|---|---|
| Market cap | CN¥19.93b |
| Earnings (TTM) | CN¥372.11m |
| Revenue (TTM) | CN¥2.53b |
53.6x
P/E Ratio7.9x
P/S RatioIs 688065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688065 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.53b |
| Cost of Revenue | CN¥1.81b |
| Gross Profit | CN¥713.75m |
| Other Expenses | CN¥341.63m |
| Earnings | CN¥372.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 28.23% |
| Net Profit Margin | 14.72% |
| Debt/Equity Ratio | 8.8% |
How did 688065 perform over the long term?
See historical performance and comparison